.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070856

« Back to Dashboard
NDA 070856 describes VERAPAMIL HYDROCHLORIDE, which is a drug marketed by Glenmark Generics, Mylan, Luitpold, Actavis Elizabeth, Pliva, Sandoz, Watson Labs, Exela Pharma Scs Llc, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Marsam Pharms Llc, Hospira, Warner Chilcott, Abraxis Pharm, Intl Medication, Par Pharm, Apotex Corp, Heritage Pharms Inc, Mutual Pharm, Bedford, Sun Pharm Inds, Solopak, and Smith And Nephew, and is included in fifty-three NDAs. It is available from thirty-five suppliers. Additional details are available on the VERAPAMIL HYDROCHLORIDE profile page.

The generic ingredient in VERAPAMIL HYDROCHLORIDE is verapamil hydrochloride. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

Summary for NDA: 070856

Tradename:
VERAPAMIL HYDROCHLORIDE
Applicant:
Watson Labs
Ingredient:
verapamil hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 070856

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
TABLET;ORAL 070856 ANDA Rebel Distributors Corp 21695-512 21695-512-30 30 TABLET in 1 BOTTLE (21695-512-30)
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
TABLET;ORAL 070856 ANDA Rebel Distributors Corp 21695-512 21695-512-90 90 TABLET in 1 BOTTLE (21695-512-90)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength120MG
Approval Date:Sep 24, 1986TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc